NCT03832959

Brief Summary

Catheter ablation of atrial fibrillation with electrical isolation of the pulmonary veins in the left atrium carries risk of esophagus thermal lesion. EnsoETM is a device . This study evaluates the benefit of using the EnsoETM, a device device for esophageal temperature adjustments, during catheter ablation of atrial fibrillation. Half of participants will undergo esophageal temperature adjustment during pulmonary vein catheter ablation, while the other half will undergo catheter ablation with no esophageal temperature adjustment.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable atrial-fibrillation

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable atrial-fibrillation

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 16, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 6, 2019

Completed
1 month until next milestone

Study Start

First participant enrolled

March 11, 2019

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2019

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2020

Completed
Last Updated

March 29, 2019

Status Verified

March 1, 2019

Enrollment Period

8 months

First QC Date

January 16, 2019

Last Update Submit

March 27, 2019

Conditions

Outcome Measures

Primary Outcomes (3)

  • Presence of esophageal damage

    Presence of esophageal lesions will be determined after ablation using esophagogastroscopy.

    1 day

  • Severity of esophageal damage

    Degree of esophageal lesions will be determined after ablation using esophagogastroscopy. Degree of esophageal lesions severity will be determined according to the Zargar endoscopy classification (0, I, IIa, IIb, IIIa, IIIb, IV)

    1 day

  • Presence of esophageal damage

    Presence of esophageal lesions will be determined after ablation using magnetic resonance imaging

    <48 hours

Secondary Outcomes (1)

  • Recurrence of atrial fibrillation

    1 year

Study Arms (2)

Non esophageal protection

NO INTERVENTION

Patients in this group will undergo a first atrial fibrillation catheter ablation procedure with pulmonary vein isolation to study esophageal lesions. The esophageal protection probe will not be used.

Esophageal protection

EXPERIMENTAL

Patients in this group will undergo a first atrial fibrillation catheter ablation procedure with pulmonary vein isolation, using the esophageal protection probe EnsoETM

Device: EnsoETM

Interventions

EnsoETMDEVICE

The EnsoETM is a device with a esophageal probe that can provide temperature adjustment

Esophageal protection

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (older than 18 years of age) subjected to their first pulmonary vein isolation procedure with a catheter or balloon.

You may not qualify if:

  • Patients with known esophageal deformity or evidence of esophageal trauma (for example, history of esophagectomy, previous swallowing disorders, achalasia, etc.)
  • Patients with known ingestion of acidic or caustic poison in the previous 24 hours.
  • Patients weighing less than 40 kg.
  • Patients who know they are pregnant.
  • Patients under chronic daily treatment with an proton pump inhibitor or any gastrointestinal acid suppressant.
  • Patients under 18 years of age.
  • Patients who have not signed the informed consent form.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital de la Santa Creu i Sant Pau

Barcelona, 08041, Spain

RECRUITING

Related Publications (39)

  • Tzou WS, Russo AM. Luminal esophageal temperature monitoring for the prevention of esophageal injury during left atrial ablation: LET it be? J Cardiovasc Electrophysiol. 2013 Sep;24(9):965-7. doi: 10.1111/jce.12198. Epub 2013 Jul 19. No abstract available.

    PMID: 23869691BACKGROUND
  • Nair GM, Nery PB, Redpath CJ, Lam BK, Birnie DH. Atrioesophageal fistula in the era of atrial fibrillation ablation: a review. Can J Cardiol. 2014 Apr;30(4):388-95. doi: 10.1016/j.cjca.2013.12.012. Epub 2013 Dec 20.

    PMID: 24582720BACKGROUND
  • Liu E, Shehata M, Liu T, Amorn A, Cingolani E, Kannarkat V, Chugh SS, Wang X. Prevention of esophageal thermal injury during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. 2012 Oct;35(1):35-44. doi: 10.1007/s10840-011-9655-0. Epub 2012 Jun 21.

    PMID: 22717996BACKGROUND
  • 10.5935/abc.20160078

    BACKGROUND
  • Tschabrunn CM, Silverstein J, Berzin T, Ellis E, Buxton AE, Josephson ME, Anter E. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015 Jun;17(6):891-7. doi: 10.1093/europace/euu356. Epub 2015 Mar 15.

    PMID: 25777771BACKGROUND
  • Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, Akar JG, Badhwar V, Brugada J, Camm J, Chen PS, Chen SA, Chung MK, Nielsen JC, Curtis AB, Davies DW, Day JD, d'Avila A, de Groot NMSN, Di Biase L, Duytschaever M, Edgerton JR, Ellenbogen KA, Ellinor PT, Ernst S, Fenelon G, Gerstenfeld EP, Haines DE, Haissaguerre M, Helm RH, Hylek E, Jackman WM, Jalife J, Kalman JM, Kautzner J, Kottkamp H, Kuck KH, Kumagai K, Lee R, Lewalter T, Lindsay BD, Macle L, Mansour M, Marchlinski FE, Michaud GF, Nakagawa H, Natale A, Nattel S, Okumura K, Packer D, Pokushalov E, Reynolds MR, Sanders P, Scanavacca M, Schilling R, Tondo C, Tsao HM, Verma A, Wilber DJ, Yamane T. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary. J Arrhythm. 2017 Oct;33(5):369-409. doi: 10.1016/j.joa.2017.08.001. Epub 2017 Sep 15. No abstract available.

    PMID: 29021841BACKGROUND
  • Halm U, Gaspar T, Zachaus M, Sack S, Arya A, Piorkowski C, Knigge I, Hindricks G, Husser D. Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias. Am J Gastroenterol. 2010 Mar;105(3):551-6. doi: 10.1038/ajg.2009.625. Epub 2009 Nov 3.

    PMID: 19888201BACKGROUND
  • Knopp H, Halm U, Lamberts R, Knigge I, Zachaus M, Sommer P, Richter S, Bollmann A, Hindricks G, Husser D. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014 Apr;11(4):574-8. doi: 10.1016/j.hrthm.2014.01.010. Epub 2014 Jan 10.

    PMID: 24418167BACKGROUND
  • Vaezi MF, Pandolfino JE, Vela MF. ACG clinical guideline: diagnosis and management of achalasia. Am J Gastroenterol. 2013 Aug;108(8):1238-49; quiz 1250. doi: 10.1038/ajg.2013.196. Epub 2013 Jul 23.

    PMID: 23877351BACKGROUND
  • Leite LR, Santos SN, Maia H, Henz BD, Giuseppin F, Oliverira A, Zanatta AR, Peres AK, Novakoski C, Barreto JR, Vassalo F, d'Avila A, Singh SM. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures: results of a pilot study. Circ Arrhythm Electrophysiol. 2011 Apr;4(2):149-56. doi: 10.1161/CIRCEP.110.960328. Epub 2011 Feb 15.

    PMID: 21325208BACKGROUND
  • Carroll BJ, Contreras-Valdes FM, Heist EK, Barrett CD, Danik SB, Ruskin JN, Mansour M. Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol. 2013 Sep;24(9):958-64. doi: 10.1111/jce.12180. Epub 2013 Jun 7.

    PMID: 23746064BACKGROUND
  • Hornero F, Berjano EJ. Atrial ablation and esophageal injury: comments on an experimental study. J Thorac Cardiovasc Surg. 2006 Jul;132(1):212-3; author reply 213-4. doi: 10.1016/j.jtcvs.2006.02.040. No abstract available.

    PMID: 16798355BACKGROUND
  • Deneke T, Bunz K, Bastian A, Pasler M, Anders H, Lehmann R, Meuser W, de Groot JR, Horlitz M, Haberkorn R, Mugge A, Shin DI. Utility of esophageal temperature monitoring during pulmonary vein isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation. J Cardiovasc Electrophysiol. 2011 Mar;22(3):255-61. doi: 10.1111/j.1540-8167.2010.01916.x. Epub 2010 Oct 11.

    PMID: 20958829BACKGROUND
  • Hegazy AF, Lapierre DM, Butler R, Martin J, Althenayan E. The esophageal cooling device: A new temperature control tool in the intensivist's arsenal. Heart Lung. 2017 May-Jun;46(3):143-148. doi: 10.1016/j.hrtlng.2017.03.001. Epub 2017 Apr 11.

    PMID: 28410771BACKGROUND
  • Wayne, M. The Esophageal Cooling Device: A New Way to Achieve Targeted Temperature Management. J Cardiol & Cardiovasc Ther. 5 (1), doi:10.19080/JOCCT.2017.05.555651, (2017).

    BACKGROUND
  • Markota A, Kosir AS, Balazic P, Zivko I, Sinkovic A. A Novel Esophageal Heat Transfer Device for Temperature Management in an Adult Patient with Severe Meningitis. J Emerg Med. 2017 Jan;52(1):e27-e28. doi: 10.1016/j.jemermed.2016.07.086. Epub 2016 Sep 19. No abstract available.

    PMID: 27658559BACKGROUND
  • Zivko, I., Balazic, P., Markota, A. & Sinkovic, A. in 12th Emirates Critical Care Conference (Dubai, UAE, 2016).

    BACKGROUND
  • Markota A, Fluher J, Kit B, Balazic P, Sinkovic A. The introduction of an esophageal heat transfer device into a therapeutic hypothermia protocol: A prospective evaluation. Am J Emerg Med. 2016 Apr;34(4):741-5. doi: 10.1016/j.ajem.2016.01.028. Epub 2016 Jan 28.

    PMID: 26906333BACKGROUND
  • Khan, I. et al. in 14th Annual Neurocritical Care Society Meeting (National Harbor, MD, 2016).

    BACKGROUND
  • Markota A, Kit B, Fluher J, Sinkovic A. Use of an oesophageal heat transfer device in therapeutic hypothermia. Resuscitation. 2015 Apr;89:e1-2. doi: 10.1016/j.resuscitation.2015.01.032. Epub 2015 Feb 7. No abstract available.

    PMID: 25660954BACKGROUND
  • Markota, A., Fluher, J., Balazic, P., Kit, B. & Sinkovic, A. Therapeutic hypothermia with esophageal heat transfer device. Resuscitation. 96 138, doi:10.1016/j.resuscitation.2015.09.328, (2015).

    BACKGROUND
  • Hegazy AF, Lapierre DM, Butler R, Althenayan E. Temperature control in critically ill patients with a novel esophageal cooling device: a case series. BMC Anesthesiol. 2015 Oct 19;15:152. doi: 10.1186/s12871-015-0133-6.

    PMID: 26481105BACKGROUND
  • Goury A, Voicu S, Deye N. Reply letter to: Targeted temperature management using the "Esophageal Cooling Device" after cardiac arrest (the COOL study): A feasibility and safety study. Resuscitation. 2018 Feb;123:e7-e8. doi: 10.1016/j.resuscitation.2017.12.001. No abstract available.

    PMID: 29306528BACKGROUND
  • Primozic KK, Svensek F, Markota A, Sinkovic A. Rewarming After Severe Accidental Hypothermia Using the Esophageal Heat Transfer Device: A Case Report. Ther Hypothermia Temp Manag. 2018 Mar;8(1):62-64. doi: 10.1089/ther.2017.0017. Epub 2017 Sep 21.

    PMID: 28934599BACKGROUND
  • Naiman, M. et al. An evaluation of esophageal temperature management in cases longer than 72 hours. Resuscitation. 118 e82, doi:10.1016/j.resuscitation.2017.08.198, (2017).

    BACKGROUND
  • Khan I, Haymore J, Barnaba B, Armahizer M, Melinosky C, Bautista MA, Blaber B, Chang WT, Parikh G, Motta M, Badjatia N. Esophageal Cooling Device Versus Other Temperature Modulation Devices for Therapeutic Normothermia in Subarachnoid and Intracranial Hemorrhage. Ther Hypothermia Temp Manag. 2018 Mar;8(1):53-58. doi: 10.1089/ther.2017.0033. Epub 2017 Dec 13.

    PMID: 29236581BACKGROUND
  • Williams D, Leslie G, Kyriazis D, O'Donovan B, Bowes J, Dingley J. Use of an Esophageal Heat Exchanger to Maintain Core Temperature during Burn Excisions and to Attenuate Pyrexia on the Burns Intensive Care Unit. Case Rep Anesthesiol. 2016;2016:7306341. doi: 10.1155/2016/7306341. Epub 2016 Feb 25.

    PMID: 27018074BACKGROUND
  • Kalasbail P, Makarova N, Garrett F, Sessler DI. Heating and Cooling Rates With an Esophageal Heat Exchange System. Anesth Analg. 2018 Apr;126(4):1190-1195. doi: 10.1213/ANE.0000000000002691.

    PMID: 29283916BACKGROUND
  • Berjano EJ, Hornero F. A cooled intraesophageal balloon to prevent thermal injury during endocardial surgical radiofrequency ablation of the left atrium: a finite element study. Phys Med Biol. 2005 Oct 21;50(20):N269-79. doi: 10.1088/0031-9155/50/20/N03. Epub 2005 Sep 27.

    PMID: 16204868BACKGROUND
  • Lequerica JL, Berjano EJ, Herrero M, Hornero F. Reliability assessment of a cooled intraesophageal balloon to prevent thermal injury during RF cardiac ablation: an agar phantom study. J Cardiovasc Electrophysiol. 2008 Nov;19(11):1188-93. doi: 10.1111/j.1540-8167.2008.01229.x. Epub 2008 Jun 4.

    PMID: 18554206BACKGROUND
  • Lequerica JL, Berjano EJ, Herrero M, Melecio L, Hornero F. A cooled water-irrigated intraesophageal balloon to prevent thermal injury during cardiac ablation: experimental study based on an agar phantom. Phys Med Biol. 2008 Feb 21;53(4):N25-34. doi: 10.1088/0031-9155/53/4/N01. Epub 2008 Jan 16.

    PMID: 18263938BACKGROUND
  • Arruda MS, Armaganijan L, Di Biase L, Rashidi R, Natale A. Feasibility and safety of using an esophageal protective system to eliminate esophageal thermal injury: implications on atrial-esophageal fistula following AF ablation. J Cardiovasc Electrophysiol. 2009 Nov;20(11):1272-8. doi: 10.1111/j.1540-8167.2009.01536.x. Epub 2009 Jun 30.

    PMID: 19572955BACKGROUND
  • Tsuchiya T, Ashikaga K, Nakagawa S, Hayashida K, Kugimiya H. Atrial fibrillation ablation with esophageal cooling with a cooled water-irrigated intraesophageal balloon: a pilot study. J Cardiovasc Electrophysiol. 2007 Feb;18(2):145-50. doi: 10.1111/j.1540-8167.2006.00693.x. Epub 2006 Dec 1.

    PMID: 17239114BACKGROUND
  • Scanavacca, M. I. et al. in ESC Congress 2007, 1 - 5 September Vol. 28 156 (Vienna, Austria, 2007).

    BACKGROUND
  • Kuwahara T, Takahashi A, Okubo K, Takagi K, Yamao K, Nakashima E, Kawaguchi N, Takigawa M, Watari Y, Sugiyama T, Handa K, Kimura S, Hikita H, Sato A, Aonuma K. Oesophageal cooling with ice water does not reduce the incidence of oesophageal lesions complicating catheter ablation of atrial fibrillation: randomized controlled study. Europace. 2014 Jun;16(6):834-9. doi: 10.1093/europace/eut368. Epub 2014 Jan 26.

    PMID: 24469436BACKGROUND
  • Sohara H, Satake S, Takeda H, Yamaguchi Y, Nagasu N. Prevalence of esophageal ulceration after atrial fibrillation ablation with the hot balloon ablation catheter: what is the value of esophageal cooling? J Cardiovasc Electrophysiol. 2014 Jul;25(7):686-92. doi: 10.1111/jce.12394. Epub 2014 Mar 24.

    PMID: 24576252BACKGROUND
  • Naiman M, Shanley P, Garrett F, Kulstad E. Evaluation of advanced cooling therapy's esophageal cooling device for core temperature control. Expert Rev Med Devices. 2016 May;13(5):423-33. doi: 10.1080/17434440.2016.1174573. Epub 2016 Apr 15.

    PMID: 27043177BACKGROUND
  • Naiman MI, Gray M, Haymore J, Hegazy AF, Markota A, Badjatia N, Kulstad EB. Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management. J Vis Exp. 2017 Nov 21;(129):56579. doi: 10.3791/56579.

    PMID: 29286452BACKGROUND
  • Zargar SA, Kochhar R, Mehta S, Mehta SK. The role of fiberoptic endoscopy in the management of corrosive ingestion and modified endoscopic classification of burns. Gastrointest Endosc. 1991 Mar-Apr;37(2):165-9. doi: 10.1016/s0016-5107(91)70678-0.

    PMID: 2032601BACKGROUND

MeSH Terms

Conditions

Atrial FibrillationEsophageal FistulaEsophageal DiseasesArrhythmias, Cardiac

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and SymptomsDigestive System FistulaDigestive System DiseasesGastrointestinal DiseasesFistulaPathological Conditions, Anatomical

Study Officials

  • Jose Maria Guerra Ramos, MD PhD

    Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Bieito Campos Garcia, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Patients referred for catheter ablation of atrial fibrillation (either cryoablation or radiofrequency ablation (1/1)) will be randomized to either receive or not (1/1) an esophageal temperature adjustment EnsoETM device, to evaluate its role for esophageal protection.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2019

First Posted

February 6, 2019

Study Start

March 11, 2019

Primary Completion

November 1, 2019

Study Completion

November 1, 2020

Last Updated

March 29, 2019

Record last verified: 2019-03

Data Sharing

IPD Sharing
Will not share

There is no IPD sharing plan

Locations